March 27, 2025 US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports Federal prosecutors in Manhattan are probing a claim by GSK that Pfizer delayed announcing its COVID ...

Exclusive: U.S. prosecutors probe a politically explosive tip that Pfizer in 2020 delayed announcing a successful Covid-19 vaccine until after the election that Trump lost to Biden.

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

As the respiratory syncytial virus (RSV) vaccine ... of Pfizer’s RSV vaccine in the U.S. Meanwhile, the two companies still appear to be locked in a patent battle around mRNA COVID vaccine ...

The decision had been expected by April 1, but the agency now says it needs more information before moving forward.

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

GSK has also sued Pfizer for patent infringement in the U.S. over technology in Pfizer's blockbuster COVID-19 vaccine Comirnaty. That case is still ongoing.

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the ...